Share on LinkedInShare on LinkedIn

ARTICLE · 30 MARCH 2015

CIPO Issues Revised Examination Guidance On Methods Of Medical Treatment And Dosage Regimens

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

The Canadian Intellectual Property Office (CIPO) has now released Practice Notice PN 2015-01, which relates to examination of medical treatment claims.

CanadaIntellectual Property

Summary

The Canadian Intellectual Property Office (CIPO) has now released Practice Notice PN 2015-01, which relates to examination of medical treatment claims. The Practice Notice softens some of the current examination guidelines on the patentability of dosage regimens. In this new guidance, essential claim elements which relate to a fixed dosage, a fixed dosage regimen, a patient sub-population, or to an administration site are now identified as elements which are not considered to limit a physician's professional skill or judgment, an important factor in determining subject matter eligibility.

Introduction

On March 18, 2015, the Canadian Intellectual Property Office (CIPO) released Practice Notice PN 2015-01 – "Revised Examination Practice Respecting Medical Uses", which revises previous Practice Notice PN 2013-04 (June, 2013; discussed in further detail here) regarding the examination of medical and surgical method claims in Canada. PN 2015-01 is

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from